In an AGBT presentation, one early-access user of BD's Resolve platform described how he used it to analyze gene expression from 1,200 kidney cells.
The company launched the BD FACSseq flow cytometer and BD Precise Assays for high-throughput single-cell gene-expression analysis studies at the ASHG annual meeting.
BD plans to launch a cell sorter for the genomics market over the next six months and to release an automated NGS library prep system in early 2016.
BD plans to pair Cellular Research's highly multiplexed gene expression technology with its flow cytometry platforms.
The partners will jointly promote the BD FACS single-cell sorting instrument alongside Cellular Research's molecular bar-coding technology, Precise.
The approach combines barcoding of individual mRNA molecules from single cells with next-generation sequencing.
NEW YORK (GenomeWeb) — Cellular Research said today that it is collaborating with Seven Bridges Genomics to provide customers with a "complete analysis pipeline" to run RNA sequencing experiments.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.